Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review

J Int Med Res. 2021 Jun;49(6):3000605211025367. doi: 10.1177/03000605211025367.

Abstract

Eosinophilic peritonitis (EP) is a well-described complication of peritoneal dialysis that occurs because of an overreaction to constituents that are related to the catheter or tubing, peritoneal dialysate, pathogenic infection, or intraperitoneal drug use. EP caused by antibiotic use is rare. We present the case of a patient with cefoperazone and sulbactam-related EP. A 59-year-old woman who was undergoing peritoneal dialysis presented with peritonitis with abdominal pain and turbid peritoneal dialysis. Empiric intraperitoneal cefazolin in combination with cefoperazone and sulbactam was started after peritoneal dialysis effluent cultures were performed. Her peritonitis achieved remission in 2 days with the help of cephalosporin, but she developed EP 1 week later, when her dialysate eosinophil count peaked at 49% of the total dialysate white blood cells (absolute count, 110/mm3). We excluded other possible causes and speculated that cefoperazone and sulbactam was the probable cause of EP. The patient continued treatment with cefoperazone and sulbactam for 14 days. EP resolved within 48 hours after stopping cefoperazone and sulbactam. Thus, EP can be caused by cefoperazone and sulbactam use. Physicians should be able to distinguish antibiotic-related EP from refractory peritonitis to avoid technique failure.

Keywords: Cefoperazone; adverse effect; cephalosporin; eosinophilic peritonitis; peritoneal dialysis; refractory peritonitis; sulbactam.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefoperazone / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Peritonitis* / drug therapy
  • Peritonitis* / etiology
  • Sulbactam / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Cefoperazone
  • Sulbactam